BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7078029)

  • 21. [Correlation of parameters in cholestasis].
    Resch E; Müller H; Glatz W; Schönberner H
    Z Med Lab Diagn; 1979 Aug; 20(4):202-7. PubMed ID: 41373
    [No Abstract]   [Full Text] [Related]  

  • 22. The value of combined determination of high molecular mass API and LP-X in the differential diagnosis of intrahepatic and extrahepatic obstruction.
    Schut JM; Diaz DP
    Clin Chim Acta; 1985 Jun; 148(3):221-7. PubMed ID: 4042356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in plasma high density lipoprotein cholesterol and phospholipid in acute viral hepatitis and cholestatic jaundice.
    Ahaneku JE; Olubuyide IO; Agbedana EO; Taylor GO
    J Intern Med; 1991 Jan; 229(1):17-21. PubMed ID: 1995758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of the LP-X test in differential diagnosis of jaundice.
    Seidel D; Gretz H; Ruppert C
    Clin Chem; 1973 Jan; 19(1):86-91. PubMed ID: 4345750
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum phosphohexose isomerase--its value in the differential diagnosis of jaundice.
    Cohn EM; Winsten S; Abramson EB
    Am J Gastroenterol; 1969 Feb; 51(2):101-11. PubMed ID: 5776145
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperlipidemia in cholestasis].
    Klör HU; Ditschuneit HH; Mico L; Ditschuneit H
    Z Gastroenterol; 1972 Oct; 10(6):489-94. PubMed ID: 4649047
    [No Abstract]   [Full Text] [Related]  

  • 27. [The diagnostic significance of lipoprotein-X].
    Radzevich IM; Gromashevskaia LL; Tat'ianko NV
    Vrach Delo; 1990 Jan; (1):116-9. PubMed ID: 2330694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresis.
    Franceschini G; Busnach G; Chiesa G; Sirtori CR
    Am J Med; 1991 May; 90(5):633-8. PubMed ID: 2029022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [LP-X in newborns: increased incidence of positive tests without cholestasis (author's transl)].
    Witt I; Ober M
    J Clin Chem Clin Biochem; 1976 Apr; 14(4):197-202. PubMed ID: 5573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The serum lipoprotein X (LP-X) test in the diagnosis of cholestatic hepatopathies (preliminary note)].
    Colalongo G; Nubile G; Fiorentini GP; Tabacchi L; Beltrandi E
    Boll Soc Ital Biol Sper; 1974 Sep; 50(18):1440-5. PubMed ID: 4458730
    [No Abstract]   [Full Text] [Related]  

  • 32. [The biochemical profile of the cholestatic syndrome].
    Grigorescu M; Suciu A; Tăpălagă D; Dumitraşcu D
    Med Interna; 1992; 44(2-4):34-40. PubMed ID: 1345058
    [No Abstract]   [Full Text] [Related]  

  • 33. [LP-X in the first month of life (author's transl)].
    Lachmann D; Eder G
    Padiatr Padol; 1977; 12(4):334-8. PubMed ID: 904943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of enzyme tests in the diagnosis of infectious hepatitis].
    Mierzwa A
    Przegl Lek; 1971; 28(5):358-61. PubMed ID: 5091791
    [No Abstract]   [Full Text] [Related]  

  • 35. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.
    Seidel D; Alaupovic P; Furman RH
    J Clin Invest; 1969 Jul; 48(7):1211-23. PubMed ID: 4978447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis.
    Simon JB; Poon RW
    Gastroenterology; 1978 Aug; 75(2):177-80. PubMed ID: 208914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of diagnostic significance of serum alkaline phosphatase values in differentiating hepatocellular and obstructive jaundice.
    Elibol T; Winkelman EI; King JW; Brown CH
    Cleve Clin Q; 1968 Jul; 35(3):159-67. PubMed ID: 5747185
    [No Abstract]   [Full Text] [Related]  

  • 38. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential diagnosis between intrahepatic cholestatic jaundice and viral hepatitis during pregnancy.
    Piccinino F; Manzillo G; Sagnelli E
    Acta Hepatogastroenterol (Stuttg); 1975 Jun; 22(3):144-50. PubMed ID: 1220507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse.
    Bravo I; Amigo L; Cohen DE; Nervi F; Rigotti A; Francone O; Zanlungo S
    Biochim Biophys Acta; 2007 Jun; 1770(6):979-88. PubMed ID: 17399905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.